Novel treatments in primary sclerosing cholangitis

Clin Liver Dis (Hoboken). 2016 Nov 30;8(5):132-135. doi: 10.1002/cld.588.

Ahmad H Ali ¹, Keith D Lindor ¹ ²

Affiliations

Affiliations

1 Division of Gastroenterology and Hepatology Mayo Clinic Phoenix AZ.
2 College of Health Solutions Arizona State University Phoenix AZ.

PMID: 31041081 DOI: 10.1002/cld.588

Products

Cat. No.

Product Name

Description

Target

Research Area
HY-P99323

Timolumab

98.56%, Anti-Human AOC3 Recombinant Antibody

AP-1

Inflammation/Immunology

MedChemExpress Magic Cece

MedChemExpress: Contact Us; About Us; Headquarters; Distributors; Statement on False Report; Careers

Customer Support: Technical Support; Service; Ordering Information; Easy Return; Shipping Rates & Policies; Intellectual Property Promise

Resources: Free Sample; Resources; Molarity Calculator; Dilution Calculator; Terms & Conditions; Reconstitution Calculator; Specific Activity Calculator

Subscribe to our E-newsletter

Products are chemical reagents for research use only and are not intended for human use. We do not sell to patients.

Copyright © 2013-2024 MedChemExpress. All Rights Reserved.: Site Map Privacy Policy

Join with us